#DiabetesCare #PrecisionMedicine #MetabolicHealth #LowerTheDose #HealthcareInnovation To view or add a comment, sign in In our recent publication in Diabetes, Obesity and Metabolism, together with Professors Kokkinos and le Roux, we articulate a perspective grounded in robust scientific evidence, yet one that is rarely expressed with candor in the public scientific discourse: that, as with any other chronic disease, pharmacotherapy should constitute the central pillar in the treatment of obesity, while other approaches retain an important but complementary role
Pemafibrate and fenofibrate (PPAR- agonists) have been approved for the treatment of dyslipidemia, atherosclerosis, and T2DM, effectively lowering blood lipids and improving metabolic conditions in individuals with diabetes
Tirzepatide should not be combined with other medications that may cause dangerously low blood sugar unless managed by a doctor
Does Ozempic Need To Be Refrigerated At All Times
To protect against damage to our cells from oxidative stress, we naturally produce an antioxidant called glutathione
If tracking grams feels tedious, use the simpler approximation of 0.7 to 1 gram per pound of body weight